A New Pharmaceutical World Order
IMS Health says it is difficult to build a commercial business model because of the differences between medical markets in different areas of the world.
-
Emerging pharmaceutical markets are experiencing growth despite the global... -
M&A deals with companies such as the UK's GSK and firms in South Africa... -
IMS Health says it is difficult to build a commercial business model because...
Twitter